Genmab Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,901	3,720	3,121	2,390	2,088	1,287
Revenue Growth (YoY)	27.49%	19.19%	30.59%	14.48%	62.20%	-22.45%
Cost of Revenue	115	-	-	-	-	-
Gross Profit	3,786	3,720	3,121	2,390	2,088	1,287
Selling, General & Admin	292	-	-	-	385.16	196.21
Research & Development	1,687	1,606	1,414	1,107	800.55	639.39
Other Operating Expenses	230	185	43	-	-	-
Total Operating Expenses	2,209	1,791	1,457	1,107	1,186	835.59
Operating Income	1,057	1,065	972	772	902.03	451.59
Interest Income	354	408	645	299	459	254.93
Interest Expense	-377	-269	-291	-254	-361.41	-107.35
Total Non-Operating Income (Expense)	-23	139	354	45	97.59	147.57
Pretax Income	905	1,204	1,326	817	999.61	599.17
Provision for Income Taxes	168	-	-	-	214.89	146.96
Net Income	53	963	1,133	631	784.72	452.2
Net Income to Common	53	963	1,133	631	784.72	452.2
Net Income Growth	-72.82%	-15.00%	79.56%	-19.59%	73.53%	-42.10%
Shares Outstanding (Basic)	40	622	642	653	654	654
Shares Outstanding (Diluted)	40	627	647	659	660	660
Shares Change (YoY)	-93.78%	-3.04%	-1.88%	-0.17%	-0.06%	0.24%
EPS (Basic)	1.33	1.55	1.77	0.97	1.20	0.69
EPS (Diluted)	1.32	1.54	1.75	0.96	1.19	0.68
EPS Growth	-25.16%	-12.32%	82.98%	-19.50%	75.00%	-42.86%
Shares Outstanding	642.43	642.38	661.87	660.75	659.62	657.19
Free Cash Flow	-	1,149	1,099	1,018	517.44	302.18
Free Cash Flow Growth	-	4.55%	7.96%	96.74%	71.23%	-69.95%
Free Cash Flow Per Share	-	1.83	1.70	1.54	0.78	0.46
Gross Margin	97.05%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	27.10%	28.63%	31.14%	32.30%	43.21%	35.08%
Profit Margin	18.89%	32.37%	42.49%	34.18%	37.59%	35.13%
FCF Margin	-	30.89%	35.21%	42.59%	24.78%	23.48%
EBITDA	1,057	1,136	1,032	815	954.13	489.52
EBITDA Margin	27.10%	30.54%	33.07%	34.10%	45.70%	38.03%
EBIT	1,057	1,065	972	772	902.03	451.59
EBIT Margin	27.10%	28.63%	31.14%	32.30%	43.21%	35.08%
Effective Tax Rate	18.56%	0.00%	0.00%	0.00%	21.50%	24.53%

Updated May 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q